CHEK1 and cancer: Other predicted dysregulated upstream STKs, checkpoint kinase 1 (CHK1) and cyclin-dependent kinase 5 (CDK5), play roles in cell cycle regulation, and their functional aberrations have been linked to diseases such as cancers (Kastan & Bartek 2004, Sharma & Sicinski 2020).